MyFinsight
Home
Blog
About
Contact
Back
Income Statement
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$41,350K
(14.28%↑ Y/Y)
Foreign currency
translation adjustment
$1,815K
(169.27%↑ Y/Y)
Net loss
-$43,165K
(5.38%↑ Y/Y)
Income tax recovery
-$6,372K
(13.46%↑ Y/Y)
Grants and incentives
$4,339K
(4.48%↑ Y/Y)
Interest and other
$3,643K
(-54.75%↓ Y/Y)
Loss before income
tax
-$49,537K
(6.51%↑ Y/Y)
Total other income
$7,982K
(-17.51%↓ Y/Y)
Research Fees
$8,124K
Licensing And Royalty
Revenue
$191K
Loss from operations
-$57,519K
(8.20%↑ Y/Y)
Total revenue
$8,315K
(96.34%↑ Y/Y)
Total operating
expenses
$65,834K
(-1.59%↓ Y/Y)
Research and development
$46,662K
(9.80%↑ Y/Y)
Sales, general, and
administrative
$12,334K
Depreciation and
amortization
$6,838K
(28.27%↑ Y/Y)
Back